The Role of Pathology Correlation Approach in Prostate Cancer Index Lesion Detection and Quantitative Analysis with Multiparametric MRI
暂无分享,去创建一个
Andriy Fedorov | Fiona M. Fennessy | Tobias Penzkofer | Mark G. Vangel | Michelle S. Hirsch | Robert V. Mulkern | Clare M. Tempany | F. Fennessy | C. Tempany | M. Vangel | R. Mulkern | M. Hirsch | T. Flood | T. Penzkofer | Paul Masry | Trevor A. Flood | Paul Masry | Andrey Fedorov
[1] A. Svindland,et al. 1061 Detection of the index tumor and tumor volume in prostate cancer using T2w and DW MRI alone , 2014 .
[2] Jan van der Meulen,et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.
[3] Andriy Fedorov,et al. Practical considerations in T1 mapping of prostate for dynamic contrast enhancement pharmacokinetic analyses. , 2012, Magnetic resonance imaging.
[4] Evis Sala,et al. Dynamic contrast‐enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease , 2010, Magnetic resonance in medicine.
[5] Bin Wang,et al. Diffusion‐weighted imaging of prostate cancer: Correlation between apparent diffusion coefficient values and tumor proliferation , 2009, Journal of magnetic resonance imaging : JMRI.
[6] A. Evans,et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.
[7] E. Rostrup,et al. Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.
[8] J. A. Campbell,et al. ACADEMIC RADIOLOGY. , 1965, The American journal of roentgenology, radium therapy, and nuclear medicine.
[9] H. Hricak,et al. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.
[10] Henry Rusinek,et al. Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co‐registration software , 2014, BJU international.
[11] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[12] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[13] L. Turnbull,et al. Description of magnetic resonance imaging‐derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions , 2009, BJU international.
[14] Jason A Koutcher,et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.
[15] P. Choyke,et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer , 2013, Cancer.
[16] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[17] M Bolla,et al. EAU guidelines on prostate cancer . Part I : screening , diagnosis , and treatment of clinically localised disease , 2012 .
[18] Theodorus H van der Kwast,et al. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. , 2011, The Journal of urology.
[19] N. Rofsky,et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. , 2004, Radiology.
[20] M. Rubin,et al. Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features. , 2000, The Journal of urology.
[21] T. Stamey,et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.
[22] A. Svindland,et al. Detection of the index tumour and tumour volume in prostate cancer using T2‐weighted and diffusion‐weighted magnetic resonance imaging (MRI) alone , 2014, BJU international.
[23] Silvia D. Chang,et al. Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.
[24] V. Reuter,et al. Clinical significance of repeat sextant biopsies in prostate cancer patients. , 1997, Urology.
[25] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[26] Magnus Hellström,et al. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens , 2006, Virchows Archiv.
[27] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[28] T. Stamey,et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. , 2003, The Journal of urology.
[29] Milan Sonka,et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. , 2012, Magnetic resonance imaging.
[30] Ron Kikinis,et al. Statistical validation of image segmentation quality based on a spatial overlap index. , 2004, Academic radiology.
[31] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[32] Aaron Fenster,et al. Prostate: registration of digital histopathologic images to in vivo MR images acquired by using endorectal receive coil. , 2012, Radiology.
[33] Lara Dyke. Magnetic Resonance Angiography: Principles and Applications. , 2013, Medical physics.
[34] Y. Liu,et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. , 2008, Clinical radiology.
[35] Thomas Wiegel,et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.
[36] Theodore L. DeWeese,et al. Localized Prostate Cancer , 2007 .
[37] F. Beuvon,et al. Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation? , 2014, The Journal of urology.
[38] Bing Ma,et al. Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[39] Baris Turkbey,et al. Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. , 2012, Urology.
[40] P. Walsh,et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. , 1997, The Journal of urology.
[41] Stephan E Maier,et al. Multiparametric MRI of prostate cancer: An update on state‐of‐the‐art techniques and their performance in detecting and localizing prostate cancer , 2013, Journal of magnetic resonance imaging : JMRI.
[42] Baris Turkbey,et al. Correlation of magnetic resonance imaging tumor volume with histopathology. , 2012, The Journal of urology.
[43] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[44] I. Thompson,et al. Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. , 1998, The Journal of urology.